Betty S. Pace

3.3k total citations
112 papers, 2.3k citations indexed

About

Betty S. Pace is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Betty S. Pace has authored 112 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Genetics, 69 papers in Molecular Biology and 44 papers in Hematology. Recurrent topics in Betty S. Pace's work include Hemoglobinopathies and Related Disorders (93 papers), Epigenetics and DNA Methylation (41 papers) and Iron Metabolism and Disorders (36 papers). Betty S. Pace is often cited by papers focused on Hemoglobinopathies and Related Disorders (93 papers), Epigenetics and DNA Methylation (41 papers) and Iron Metabolism and Disorders (36 papers). Betty S. Pace collaborates with scholars based in United States, China and Canada. Betty S. Pace's co-authors include Yaqin Li, B. Surendra Baliga, Susan P. Perrine, Solomon F. Ofori‐Acquah, Levi Makala, Douglas V. Faller, Sima Zein, Steven R. Goodman, Athena Starlard‐Davenport and José Sangerman and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Betty S. Pace

107 papers receiving 2.2k citations

Peers

Betty S. Pace
Susan P. Perrine United States
Theodosia A. Kalfa United States
Edward J. Benz United States
G Stamatoyannopoulos United States
T. R. Rutherford United Kingdom
G. Stamatoyannopoulos United States
Julio C. Barredo United States
Véronique Picard France
Josep Nomdedéu Spain
Cristina Sanz Spain
Susan P. Perrine United States
Betty S. Pace
Citations per year, relative to Betty S. Pace Betty S. Pace (= 1×) peers Susan P. Perrine

Countries citing papers authored by Betty S. Pace

Since Specialization
Citations

This map shows the geographic impact of Betty S. Pace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty S. Pace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty S. Pace more than expected).

Fields of papers citing papers by Betty S. Pace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty S. Pace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty S. Pace. The network helps show where Betty S. Pace may publish in the future.

Co-authorship network of co-authors of Betty S. Pace

This figure shows the co-authorship network connecting the top 25 collaborators of Betty S. Pace. A scholar is included among the top collaborators of Betty S. Pace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty S. Pace. Betty S. Pace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Starlard‐Davenport, Athena, Chithra D. Palani, Xingguo Zhu, & Betty S. Pace. (2025). Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation—A Short Review. International Journal of Molecular Sciences. 26(9). 4192–4192. 1 indexed citations
3.
4.
Palani, Chithra D., et al.. (2023). Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors. Blood Cells Molecules and Diseases. 104. 102792–102792. 5 indexed citations
5.
Barrett, Patricia, Betty S. Pace, Morgan L. McLemore, et al.. (2023). Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999–2020. SHILAP Revista de lepidopterología. 3(1). 100158–100158. 8 indexed citations
6.
Starlard‐Davenport, Athena, et al.. (2022). Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option. Molecular Diagnosis & Therapy. 26(5). 497–509. 14 indexed citations
7.
Starlard‐Davenport, Athena, et al.. (2021). Exploring epigenetic and microRNA approaches for γ-globin gene regulation. Experimental Biology and Medicine. 246(22). 2347–2357. 13 indexed citations
8.
Pace, Betty S., Athena Starlard‐Davenport, & Abdullah Kutlar. (2021). Sickle cell disease: progress towards combination drug therapy. British Journal of Haematology. 194(2). 240–251. 23 indexed citations
9.
Brim, Hassan, James G. Taylor, Muneer Abbas, et al.. (2021). The gut microbiome in sickle cell disease: Characterization and potential implications. PLoS ONE. 16(8). e0255956–e0255956. 29 indexed citations
10.
Starlard‐Davenport, Athena, et al.. (2019). MIR29B mediates epigenetic mechanisms of HBG gene activation. British Journal of Haematology. 186(1). 91–100. 16 indexed citations
11.
12.
Peterson, Kenneth R., Halyna Fedosyuk, Renee Neades, et al.. (2014). A Cell-Based High-Throughput Screen for Novel Chemical Inducers of Fetal Hemoglobin for Treatment of Hemoglobinopathies. PLoS ONE. 9(9). e107006–e107006. 20 indexed citations
13.
Li, Yaqin, Lianghao Ding, Wei Li, Michael D. Story, & Betty S. Pace. (2012). Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation. BMC Genomics. 13(1). 153–153. 19 indexed citations
14.
Muralidhar, Shalini, et al.. (2008). High-density SNP genotyping to define β-globin locus haplotypes. Blood Cells Molecules and Diseases. 42(1). 16–24. 19 indexed citations
15.
Li, Wei, et al.. (2006). Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. Experimental Hematology. 34(3). 264–273. 28 indexed citations
16.
Yang, Yih‐Ming & Betty S. Pace. (2001). Pharmacologic Induction of Fetal Hemoglobin Synthesis: Cellular and Molecular Mechanisms. Pediatric Pathology & Molecular Medicine. 20(1). 87–106. 9 indexed citations
17.
Xu, Li‐Yan, et al.. (2000). Beta globin gene inhibition by antisense RNA transcripts. Gene Therapy. 7(5). 438–444. 7 indexed citations
18.
Goodman, Steven R., Betty S. Pace, & Archil Shartava. (1998). New therapeutic approaches to sickle cell disease: targeting RBC membrane oxidative damage. Cellular & Molecular Biology Letters. 3(4). 403–411. 7 indexed citations
19.
Xu, Li‐Yan & Betty S. Pace. (1998). Modulated human globin gene expression: role for antisense expression vectors. Cellular & Molecular Biology Letters. 3(4). 423–433. 1 indexed citations
20.
Yang, Yih‐Ming, Betty S. Pace, David M. Kitchens, et al.. (1997). BFU-E colony growth in response to hydroxyurea: Correlation between in vitro and in vivo fetal hemoglobin induction. American Journal of Hematology. 56(4). 252–258. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan P. Perrine Breakdown of academic impact, for papers by Theodosia A. Kalfa Breakdown of academic impact, for papers by Edward J. Benz Breakdown of academic impact, for papers by G Stamatoyannopoulos Breakdown of academic impact, for papers by T. R. Rutherford Breakdown of academic impact, for papers by G. Stamatoyannopoulos Breakdown of academic impact, for papers by Julio C. Barredo Breakdown of academic impact, for papers by Véronique Picard Breakdown of academic impact, for papers by Josep Nomdedéu Breakdown of academic impact, for papers by Cristina Sanz
Rankless by CCL
2026